APLS Stockholders Should Contact Robbins LLP for Information About the Class Action Involving Apellis Pharmaceuticals, Inc.
August 21, 2023 13:31 ET
|
Robbins LLP
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action against Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) on behalf of persons or...
APLS Stock News: Investors with Significant Losses in Apellis Pharmaceuticals, Inc. Should Contact Robbins LLP About Recovery
August 14, 2023 18:01 ET
|
Robbins LLP
SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action against Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) on behalf of persons or...
Apellis Pharmaceuticals, Inc. (APLS) Investor Alert: Robbins LLP Reminds Shareholders of Class Action Against Apellis Pharmaceuticals, Inc.
August 07, 2023 20:24 ET
|
Robbins LLP
SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action against Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) on behalf of persons and...